Markets.com Logo
markets.com

AIMBU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    18.2245$
  • Previous Close
    18.2245$
  • 52 Week Change
    9.39$
  • Day Range
    0.00$
  • 52 Week High/Low
    10.01$ - 19.4$
  • Dividend Per Share
    --
  • Market cap
    0$
  • EPS
    --
  • Beta
    -0.237
  • Volume
    --

About

AIMBU.US is a CUSIP for the AIM Ultra Short Bond ETF. It is an exchange-traded fund (ETF) that invests primarily in U.S. dollar-denominated investment-grade fixed-income securities with an average portfolio duration of one year or less. The fund seeks to provide current income while maintaining liquidity and preserving capital.
markets.com
Week Ahead: US June inflation and BoC rate decision are on the watch

Week Ahead: US June inflation and BoC rate decision are on the watch

Darius Anucauskas|--
USD/CAD Forecast: Pair Recovers from Three-Week Low Ahead of Canadian Jobs Data

USD/CAD Forecast: Pair Recovers from Three-Week Low Ahead of Canadian Jobs Data

Julian Parker|--
XRP Price Forecast 2026–2030: Can It Reach New Highs?

XRP Price Forecast 2026–2030: Can It Reach New Highs?

Julian Parker|--
Samsung Stock Price Forecast 2026–2030: AI Memory Cycle, HBM4 Expansion, and Market Structure

Samsung Stock Price Forecast 2026–2030: AI Memory Cycle, HBM4 Expansion, and Market Structure

Julian Parker|--
Why Is SK Hynix Stock Falling Before Its Nasdaq Listing?

Why Is SK Hynix Stock Falling Before Its Nasdaq Listing?

Julian Parker|--
KOSPI takes a beating, DXY awaits for the next moving data

KOSPI takes a beating, DXY awaits for the next moving data

Darius Anucauskas|--
Silver Price Forecast: Weak US Jobs Data Lifts XAG/USD, but Risks Remain

Silver Price Forecast: Weak US Jobs Data Lifts XAG/USD, but Risks Remain

Julian Parker|--

Factors

Company Performance: AIM ImmunoTech's success in clinical trials for its drug Ampligen directly impacts the stock price.

Market Sentiment: Overall investor confidence and risk appetite affect demand for biotech stocks like AIMBU.US.

Regulatory Approvals: FDA decisions on Ampligen's approval are major price catalysts.

Competition: Competing therapies in the same disease areas influence AIMBU.US value.

Financial Health: AIM ImmunoTech's cash reserves, debt levels, and burn rate affect investor perception.

Partnerships: Collaborations with other companies can positively impact AIMBU.US stock.

People Also Watch

Latest news

SK Hynix’s $26.5 Billion Nasdaq Listing Sparks Rush for New Leveraged ETFs

SK Hynix’s $26.5 Billion Nasdaq Listing Sparks Rush for New Leveraged ETFs

Julian Parker|--
SoftBank Stock Surges 11% as OpenAI’s GPT-5.6 Revives AI Optimism

SoftBank Stock Surges 11% as OpenAI’s GPT-5.6 Revives AI Optimism

Julian Parker|--
Gold Price Holds Above $4,100 as Weaker Dollar Offsets Fed Rate Hike Risks

Gold Price Holds Above $4,100 as Weaker Dollar Offsets Fed Rate Hike Risks

Julian Parker|--

Latest Education Articles

5 Best CFD Brokers with Welcome Bonus in 2026

5 Best CFD Brokers with Welcome Bonus in 2026

Julian Parker|--
10 Best CFD Demo Accounts in the UAE

10 Best CFD Demo Accounts in the UAE

Julian Parker|--
10 Best CFD Brokers for Beginners in the UAE 2026

10 Best CFD Brokers for Beginners in the UAE 2026

Julian Parker|--
Recommended Topics
markets.com